[MAHARASHTRA] API Holdings is weighing a new funding round that could value the owner of India's largest online pharmacy chain at about US$4 billion, according to people familiar with the matter.
The company is considering raising about US$300 million and its existing investors including TPG Capital and Temasek Holdings could participate, said the people, who asked not to be identified as the discussions are private.
API, which owns India's first e-pharmacy unicorn PharmEasy, intends to use the proceeds for potential acquisitions particularly in the diagnostic area, one of the people said.
A new round would mark the second fundraising by API Holdings within a few months after securing about US$350 million in April. The firm last raised funds from a clutch of investors including Prosus Ventures, TPG and Temasek, according to a press release at that time.
PharmEasy has so far delivered more than 15 million orders from medicine to diagnostic kits to healthcare products, serving over five million families, according to its website.
Deliberations are ongoing and details of the fundraising could still change, the people said. Siddharth Shah, API's co-founder and chief executive officer, didn't respond to messages for comment, while representatives for Temasek and TPG declined to comment.
精彩评论